Related Experiment Video
Updated: Aug 5, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Association of hepatitis C virus & hepatitis B virus in chronic liver disease
N Berry1, A Chakravarti, P Kar
1Department of Microbiology, Maulana Azad Medical College, New Delhi.
Insights
Hepatitis C virus (HCV) is a significant cause of chronic liver disease (CLD), often co-infecting with Hepatitis B virus (HBV). Combining ELISA and RT-PCR offers reliable HCV detection.
Area of Science:
- Hepatology
- Virology
- Clinical Diagnostics
Background:
- Chronic liver disease (CLD) encompasses conditions like chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
- Hepatitis C virus (HCV) is a major global health concern contributing to CLD.
- Understanding the interplay between HCV, Hepatitis B virus (HBV), and CLD is crucial for effective management.
Purpose of the Study:
- To assess the role of HCV in causing CLD among 55 patients.
- To determine the prevalence of HCV RNA and its correlation with serological markers.
- To evaluate the co-infection rate of HBV in HCV-positive CLD patients.
Main Methods:
- Serum samples from 55 CLD patients were tested for anti-HCV antibodies using ELISA.
- HCV RNA was detected via reverse transcription polymerase chain reaction (RT-PCR).
- HBV markers (anti-HBc IgG/IgM, HBsAg) were assessed to evaluate HBV co-infection.
Main Results:
- HCV infection was detected in 40% (22/55) of CLD patients.
- A significant proportion (77.3%) of HCV-positive patients showed evidence of HBV infection or past exposure.
- ELISA and RT-PCR demonstrated comparable sensitivity for HCV detection (P > 0.05).
Conclusions:
- HCV is a primary cause of CLD, second only to HBV in this patient cohort.
- HCV and HBV frequently co-infect patients with CLD.
- Concomitant use of ELISA and RT-PCR is recommended for accurate HCV diagnosis.
Abstract:
Hepatitis C virus (HCV) as a cause of chronic liver disease (CLD) was assessed by testing anti-HCV antibodies in the serum samples of 55 patients of chronic hepatitis (17), cirrhosis (32) and hepatocellular carcinoma (6). All the samples were also tested for the presence of HCV RNA by reverse transcription polymerase chain reaction (RT-PCR) using primers from the 5' non-coding region (NCR) and the relationship between the serological parameters and presence of HCV RNA was studied. The association of hepatitis B virus (HBV) with HCV in this group was evaluated by testing for the anti HBc antibodies (IgG and IgM separately) and HBsAg. The biochemical parameters and involvement of other risk factors were also studied. Twenty two (40%) patients were found to be HCV positive and 17 (77.3%) of these had evidence of infection or past exposure to HBV. On comparing the sensitivities of ELISA with that of PCR for the detection of HCV, we observed no significant difference between the two methods (P > 0.05, McNemar's test). Eighteen patients had no evidence of HBV or HCV infection. Our results indicate that HCV is next only to HBV in the causation of CLD. It is suggested that RT-PCR be used with antibody detection by ELISA for reliable detection of HCV infection.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Viruses with RNA Genomes
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction

